Trade name : Pazmito FCT
Active principle : Dimethicon 40 mg , mebeverine HCL 135 mg
Indications : symptomatic treatment of irritable bowel syndrome and other conditions such as chronic irritable colon, spastic constipation, mucous colitis, spastic colitis
Dose : One tablet three times a day, preferably 20 minutes before meals. After a period of several weeks, when the desired effect has been obtained, the dosage may be gradually reduced.
